For many patients with major depressive disorder (MDD) and bipolar disorder (BD), conventional pharmacotherapy is not effective. Up to one-third of patients with MDD do not respond to conventional anti-depressants and treatment resistance often occurs for patients with BD depression despite extensive trials with numerous pharmacologic agents.